$IBIO investors.emergentbiosoluti... Emergent BioSolutions is deploying its decades of experience in vaccine and hyperimmune development and manufacturing, as well as its molecule-to-market contract development and manufacturing (CDMO) services to provide comprehensive medical countermeasure solutions in response to the COVID-19 pandemic. -- So why isn't iBio doing this? Maybe because they are reserving their production for their own vaccines?
  • 6
6 Likes